Nanobiotix Presents Results of NBTXR3 (PEP503) in P-Ib/II Study for Rectal Cancer at ASCO-GI 2021
PharmaShots Weekly Snapshot (February 03-07, 2020)
Published: Feb 06, 2020 | Tags: WHO, Accelerate, Global, Research, Innovation, Against, Corona Virus
Published: Feb 07, 2020 | Tags: Curis, Amends, Existing Collaboration, Aurigene, Development, Commercialization, CA-170
3. Novo Nordisk to Invest ~$117.4M in Expansion of its Production Facilities in Denmark
Published: Feb 07, 2020 | Tags: Novo Nordisk, Invest, ~$117.4M, Expansion, Production Facilities, Denmark
4. Collegium to Acquire US Rights of Assertio’s Nucynta Franchise for $375M
Published: Feb 06, 2020 | Tags: Collegium, Acquire, US, Rights, Assertio, Nucynta Franchise, $375M
5. Merck & Co. to Initiate P-II Study of MK-5890 for Non-Small Cell Lung Cancer
Published: Feb 06, 2020 | Tags: Merck & Co., Initiates, P-II, Study, MK-5890, Non-Small Cell Lung Cancer
Published: Feb 07, 2020 | Tags: Roche, Reports, Results, Tecentriq, atezolizumab, Avastin, bevacizumab, P-III, IMbrave150 Study, Chinese Patients, Hepatocellular Carcinoma
7. Almirall Collaborates with Plug and Play to Offer Digital Solutions in Dermatology
Published: Feb 06, 2020 | Tags: Almirall, Collaborates, Plug and Play, Offer, Digital Solutions, Dermatology
Published: Feb 06, 2020 | Tags: Bridge Biotherapeutics, Signs, License Agreement, Konkuk University, Back-Eye Disease Therapy
Published: Feb 05, 2020 | Tags: Nestle Health Science, Signs, Worldwide, Exclusive Agreement, VALBIOTIS, Develop, Commercialize, TOTUM-63, Reducing, T2D
Published: Feb 06, 2020 | Tags: Roche, Reports, Results, Risdiplam, SUNFISH Part 2, Study, Patients, Type 2 Or 3, Spinal Muscular Atrophy
Published: Feb 05, 2020 | Tags: Fresenius Kabi, Reports, Availability, Glucagon Emergency Medicine Kit, Hypoglycemia, US
12. Sanofi Reports Results of SAR442168 in P-IIb Study for Relapsing Multiple Sclerosis
Published: Feb 06, 2020 | Tags: Sanofi, Reports, Results, SAR442168, P-IIb, Study, Relapsing Multiple Sclerosis
13. Merck & Co. Collaborates with Atreca to Identify Novel Antibody Targets in Oncology
Published: Feb 05, 2020 | Tags: Merck & Co., Collaborates, Atreca, Identify, Novel Antibody Targets, Oncology
14. Johnson & Johnson Initiates the Development of Vaccines Against Coronavirus
Published: Feb 06, 2020 | Tags: Johnson & Johnson, Initiates, Development, Vaccines, Coronavirus
15. Alector’s AL101 Receives FDA’s Fast Track Designation to Treat Frontotemporal Dementia
Published: Feb 05, 2020 | Tags: Alector, AL101, Receives, FDA, Fast Track Designation, Treat, Frontotemporal Dementia
16. Navrogen and Levena Collaborate to Develop ADCs for Humoral Immuno-Suppressed Cancers
Published: Feb 05, 2020 | Tags: Navrogen, Levena, Collaborate, ADCs, Humoral Immuno-Suppressed Cancers
Published: Feb 03, 2020 | Tags: Seqirus, Audenz, Receives, US, FDA, Approval, First, Adjuvanted, Cell-Based, Pandemic, Influenza A, H5N1 Vaccine
18. Merck & Co. to Spin-Off its Non-Core Business into a New Company to Focus on its Core Therapy Areas
Published: Feb 05, 2020 | Tags: Merck, Spin -Off, Non-Core Business, New Company, Core Therapy Areas
19. The US FDA Grants Emergency Use Authorization for Coronavirus Diagnostic Test
Published: Feb 04, 2020 | Tags: US, FDA, Grants, Emergency Use Authorization, Coronavirus Diagnostic Test
20. AbbVie’s Rinvoq (upadacitinib) Receives ANVISA’s Approval for Rheumatoid Arthritis
Published: Feb 04, 2020 | Tags: AbbVie, Rinvoq, upadacitinib, Receives, ANVISA, Approval, Rheumatoid Arthritis
21. BioMotiv and BMS to Launch Anteros Pharmaceuticals
Published: Feb 05, 2020 | Tags: BioMotiv, BMS, Launch, Anteros Pharmaceuticals
Published: Feb 04, 2020 | Tags: Regeneron, Expands, Existing Collaboration, HHS, BARDA, Develop, Antibody Therapies, Coronavirus
Published: Feb 04, 2020 | Tags: GSK, Reports, EMA, Acceptance, MAA, Belantamab Mafodotin, Treat, Relapsed or Refractory, Multiple Myeloma
24. CELLINK Expands its Multi-Target Collaboration with AstraZeneca for Drug Discovery
Published: Feb 04, 2020 | Tags: CELLINK, Expands, Multi-Target, Collaboration, AstraZeneca, Drug Discovery
Published: Feb 04, 2020 | Tags: Boehringer Ingelheim, Reports, Real-World Data, Spiriva Respimat, (tiotropium bromide), Inhalation Spray, 1.25mcg, Patients, Asthma
26. Kyowa Kirin Terminates its Agreement with Zeria Pharmaceuticals for ASACOL (mesalazine)
Published: Feb 04, 2020 | Tags: Kyowa Kirin, Terminates, Agreement, Zeria Pharmaceuticals, ASACOL, (mesalazine)
Published: Feb 04, 2020 | Tags: Bio-Thera, Reports, Results, BAT1706, biosimilar, bevacizumab, P-III, Non-Squamous Non-Small Cell Lung Cancer, NSCLC
Published: Feb 04, 2020 | Tags: IMIDomics, Collaborates, Gossamer Bio, Develop, Therapies, Treating, Immune-Mediated Inflammatory Diseases
29. Danaher Receives S.Korean FTC’s Conditional Approval for its $21.4B GE Biopharma Acquisition
Published: Feb 04, 2020 | Tags: Danaher, Receives, S.Korean FTC, Conditional Approval, $21.4B, GE Biopharma Acquisition
Published: Feb 03, 2020 | Tags: Amgen, Launches, Amgevita, biosimilar, adalimumab, Treatment, Inflammatory Diseases, Brazil
Published: Jan 31, 2020 | Tags: Pfizer, Ruxience, biosimilar, rituximab, Receives, CHMP, Positive Opinion, Cancer, Autoimmune Diseases
Published: Feb 03, 2020 | Tags: Teva, Reports, Results, Ajovy, fremanezumab, Two, P-II/III, Clinical Studies, Treatment, Migraine, Japan
33. GSK Collaborates with CEPI to Develop Vaccine Against Corona Virus
Published: Feb 03, 2020 | Tags: GSK, Collaborates, CEPI, Develop, Vaccine, Against, Corona Virus
34. Eli Lilly Launches Reyvow (lasmiditan) C-V for the Treatment of Migraine in the US
Published: Feb 03, 2020 | Tags: Eli Lilly, Launches, Reyvow, lasmiditan, C-V, Treatment, Migraine, US